Enbridge Turns To Profit In Q1

Enbridge Inc. (ENB.TO,ENB) reported a first quarter GAAP earnings of C$1.9 billion or C$0.94 per share, compared to a GAAP loss of C$1.4 billion or C$0.71 per share in 2020.

Adjusted earnings of C$1.6 billion or C$0.81 per share, compared to C$1.7 billion or C$0.83 per share in 2020.

The company reaffirmed 2021 full year guidance range of EBITDA of C$13.9 billion to C$14.3 billion and DCF per share of C$4.70 to C$5.00.

The company continues to expect full year 2021 EBITDA and DCF within the previously provided guidance range of $13.9 to $14.3 billion and $4.70 to $5.00 per share, respectively.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Flavor maker McCormick & Co., Inc. is recalling certain McCormick and Frank's brand seasoning products citing possible salmonella risk, the U.S. Food and Drug Administration said. The recall involves McCormick Perfect Pinch Italian Seasoning, McCormick Culinary Italian Seasoning and Frank's RedHot Buffalo Ranch Seasoning. Drug major Pfizer Inc. raised Wednesday its outlook for fiscal 2021 earnings and revenues following strong second quarter results that exceeded market estimates. According to the company, the upward revision in full-year outlook, for the second quarter in a row, reflects its updated expectations for contributions to 2021 performance from both BNT162b2, the Pfizer-BioNTech SE COVID-19 vaccine. While reporting financial results for the second quarter on Wednesday, biopharmaceutical company Bristol-Myers Squibb Co. (BMY) reaffirmed its adjusted earnings and revenue growth guidance for the full-year 2021. For fiscal 2021, the company now projects earnings in a range of $3.18 to $3.38 per share,...
Follow RTT